Increased killing of prostate, breast, colon, and lung tumor cells by the combination of inactivators of O6-alkylguanine-DNA alkyltransferase and N,N'-bis(2-chloroethyl)-N-nitrosourea.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Biochemical Pharmacology

• Publication date

  1995-10-12

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-2952(95)00249-YPMID 7488227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bioditribution ofO6-benzylguanine and its effectiveness against human brain tumor xenografts when given in polyethylene glycol or cremophor-EL

  2004cited by this paper
• Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase.

  1995cited by this paper
• 8-Substituted O6-benzylguanine, substituted 6(4)-(benzyloxy)pyrimidine, and related derivatives as inactivators of human O6-alkylguanine-DNA alkyltransferase.

  1995cited by this paper
• Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity.

  1994cited by this paper
• Mutations in human O6-alkylguanine-DNA alkyltransferase imparting resistance to O6-benzylguanine.

  1994cited by this paper
• Substituted O6-benzylguanine derivatives and their inactivation of human O6-alkylguanine-DNA alkyltransferase.

  1994cited by this paper
• Metabolism of O6-benzylguanine, an inactivator of O6-alkylguanine-DNA alkyltransferase.

  1994cited by this paper
• Regulation of repair of alkylation damage in mammalian genomes.

  1993cited by this paper
• A single amino acid change in human O6-alkylguanine-DNA alkyltransferase decreasing sensitivity to inactivation by O6-benzylguanine.

  1993cited by this paper
• Mechanism of inactivation of human O6-alkylguanine-DNA alkyltransferase by O6-benzylguanine.

  1993cited by this paper
• Synergistic efficacy of O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU alone.

  1993cited by this paper
• Prolonged depletion of O6-methylguanine DNA methyltransferase activity following exposure to O6-benzylguanine with or without streptozotocin enhances 1,3-bis(2-chloroethyl)-1-nitrosourea sensitivity in vitro.

  1993cited by this paper
• Structural features of substituted purine derivatives compatible with depletion of human O6-alkylguanine-DNA alkyltransferase.

  1992cited by this paper
• Repair of DNA containing O6‐alkylguanine

  1992cited by this paper
• Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme.

  1992cited by this paper
• Identification of the cross-link between human O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea-treated DNA.

  1992cited by this paper
• Enhancement of Nitrosourea Activity in Medulloblastoma and Glioblastoma Multiforme

  1992cited by this paper
• Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation.

  1992cited by this paper
• Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents.

  1991cited by this paper
• Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents.

  1990cited by this paper
• DNA alkylation by the haloethylnitrosoureas: nature of modifications produced and their enzymatic repair or removal.

  1990cited by this paper
• Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents.

  1990cited by this paper
• Cancer Chemotherapy: Principles and Practice

  1990cited by this paper
• Contributions of nitrosoureas to cancer treatment.

  1986cited by this paper
• Effect of O6-alkylguanine pretreatment on the sensitivity of human colon tumor cells to the cytotoxic effects of chloroethylating agents.

  1986cited by this paper
• Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems.

  1986cited by this paper
• Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems.

  1986cited by this paper
• Isolation and purification of O6-alkylguanine-DNA alkyltransferase from human leukemic cells. Prevention of chloroethylnitrosourea-induced cross-links by purified enzyme.

  1985cited by this paper
• Correlation between O6-methylguanine-DNA-methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of N-methyl-N'-nitro-N-nitrosoguanidine.

  1984cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Synthesis of Oligonucleotides Carrying Nucleic Acid Derivatives of Biomedical and Structural Interest

  2018cites this paper
• Patent Application Publication Nov . 8 , 2012 Sheet 1 of 8 US 2012 / 0283280 A 1

  2017cites this paper
• Synthesis of oligonucleotides carrying fluorescently labelled O(6)-alkylguanine for measuring hAGT activity.

  2015cites this paper
• Untersuchung von Nukleinsäuren mit Hilfe von neuen Simulationsmethoden

  2014cites this paper
• “Combi‐targeting” mitozolomide: Conferring novel signaling inhibitory properties to an abandoned DNA alkylating agent in the treatment of advanced prostate cancer

  2012cites this paper
• MGMT: A Critical DNA Repair Gene Target for Chemotherapy Resistance and for Stem Cell Protection

  2012cites this paper
• In vitro comparison of O4-benzylfolate modulated, BCNU-induced toxicity in human bone marrow using CFU-GM and tumor cell lines

  2010cites this paper
• Development of a Novel Fluorescence Assay Based on the Use of the Thrombin-Binding Aptamer for the Detection of O6-Alkylguanine-DNA Alkyltransferase Activity

  2010cites this paper
• Übersehenes sichtbar gemacht: ATL-Proteine und DNA-Reparatur†

  2009cites this paper
• Once overlooked, now made visible: ATL proteins and DNA repair.

  2009cites this paper
• Structure-Based Discovery of Novel Non-nucleosidic DNA Alkyltransferase Inhibitors: Virtual Screening and in Vitro and in Vivo Activities

  2008cites this paper
• Survival and tumorigenesis in O6-methylguanine DNA methyltransferase-deficient mice following cyclophosphamide exposure.

  2008cites this paper
• The Combi-Targeting Concept: In vitro and In vivo Fragmentation of a Stable Combi-Nitrosourea Engineered to Interact with the Epidermal Growth Factor Receptor while Remaining DNA Reactive

  2007cites this paper
• Inactivation of O(6)-alkylguanine-DNA alkyltransferase by folate esters of O(6)-benzyl-2'-deoxyguanosine and of O(6)-[4-(hydroxymethyl)benzyl]guanine.

  2007cites this paper
• Gene Transfer for Chemoprotection and Enrichment of Hematopoietic Stem Cells

  2007cites this paper
• Molecular imaging of alkylguanine-DNA alkyltransferase: further evaluation of radioiodinated derivatives of O6-benzylguanine.

  2006cites this paper
• - nitrosourea N-Bis ( 2-chloroethyl )-′ N , N-Benzylguanine to Killing by 6 O Alkyltransferase Prevent the Sensitization by-Alkylguanine-DNA 6 O Point Mutations in Human Updated

  2006cites this paper
• Role of O6-methylguanine-DNA methyltransferase in protecting from alkylating agent-induced toxicity and mutations in mice.

  2006cites this paper
• Inactivation of O6-alkylguanine DNA alkyltransferase as a means to enhance chemotherapy.

  2006cites this paper
• Characterisation of a P140K mutant O6‐methylguanine‐DNA‐methyltransferase (MGMT)‐expressing transgenic mouse line with drug‐selectable bone marrow

  2006cites this paper
• Dual-Gene Transfer and Vector Targeting for Hematopoietic Stem Cell Gene Therapy

  2006cites this paper
• Grupo de Trabajo

  2006cites this paper
• 06-Benzylguanine and Its Role in Chemotherapy1

  2005cites this paper
• Molecular modeling of O6-methylguanine-DNA methyltransferase mutant proteins encoded by single nucleotide polymorphisms.

  2005cites this paper
• Overcoming Resistance to Alkylating Agents by Inhibitors of O 6-Alkylguanine-DNA Alkyltransferase

  2004cites this paper
• The reactivity of N-2-(4-amino-1,6-dihydro-1-methyl-5-nitroso-6-oxo-pyrimidinyl)-L-histidine towards silver(I) and zinc(II) ions

  2002cites this paper
• Clinical relevance of MGMT in the treatment of cancer.

  2002cites this paper
• The reactivity of N-2-(4-amino-1,6-dihydro-1-methyl-5-nitroso-6-oxopyrimidinyl)-L-histidine towards copper(II) ions

  2001cites this paper
• Inactivation of human O(6)-alkylguanine-DNA alkyltransferase by modified oligodeoxyribonucleotides containing O(6)-benzylguanine.

  2001cites this paper
• Repair of O6-alkylguanine by alkyltransferases

  2000cites this paper
• O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.

  2000cites this paper
• The human cyclin B1 protein modulates sensitivity of DNA mismatch repair deficient prostate cancer cell lines to alkylating agents.

  2000cites this paper
• Potentiation of BCNU antitumor efficacy by 9-substituted O6-benzylguanines. Effect of metabolism

  2000cites this paper
• Role of polymorphisms in codons 143 and 160 of the O6-alkylguanine DNA alkyltransferase gene in lung cancer risk.

  2000cites this paper
• Conserved structural motifs governing the stoichiometric repair of alkylated DNA by O(6)-alkylguanine-DNA alkyltransferase.

  2000cites this paper
• O6-(Fluorobenzyl)Guanine and Chloroethylnitrosourea in Xenografted Rat Brain Tumor In Vivo

  2000cites this paper
• Repair of O(6)-alkylguanine by alkyltransferases.

  2000cites this paper
• Short Communication Role of Polymorphisms in Codons 143 and 160 of the O 6 -Alkylguanine DNA Alkyltransferase Gene in Lung Cancer Risk 1

  2000cites this paper
• Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine.

  1999cites this paper
• Synthesis and structural characterization of Zn (II), Ag (I) and Pd (II) complexes with 2,4-diamino-5-nitroso-6-oxopyrimidine. Crystal and molecular structure of [ZnCl2 (L) (H2O)] and [Ag (NO3) (L)2]

  1999cites this paper
• Activation of human O6-methylguanine-DNA methyltransferase gene by glucocorticoid hormone

  1999cites this paper
• Eradication of human medulloblastoma tumor xenografts with a combination of O6-benzyl-2'-deoxyguanosine and 1,3-bis(2-chloroethyl)1-nitrosourea.

  1999cites this paper
• Expression of the inactive C145A mutant human O6-alkylguanine-DNA alkyltransferase in E.coli increases cell killing and mutations by N-methyl-N'-nitro-N-nitrosoguanidine.

  1999cites this paper
• Reactivity of N-(6-amino-3-methyl-5-nitroso-4-oxo-3,4-dihydro- pyrimidin-2-yl)glycine with FeII, CoII, NiII, CdII and HgII metal ions

  1998cites this paper
• Modulation of O6-alkylating agent induced clastogenicity by enhanced DNA repair capacity of bone marrow cells.

  1998cites this paper
• Inhibition of human O6-alkylguanine-DNA alkyltransferase and potentiation of the cytotoxicity of chloroethylnitrosourea by 4(6)-(benzyloxy)-2,6(4)-diamino-5-(nitro or nitroso)pyrimidine derivatives and analogues.

  1998cites this paper
• DNA repair mechanisms associated with cellular resistance to antitumor drugs: potential novel targets.

  1998cites this paper
• Effect of DNA on the inactivation of O6-alkylguanine-DNA alkyltransferase by 9-substituted O6-benzylguanine derivatives.

  1997cites this paper
• Repair of O6-Benzylguanine by the Escherichia coli Ada and Ogt and the Human O6-Alkylguanine-DNA Alkyltransferases*

  1997cites this paper
• Inhibition of DNA repair as a means of increasing the antitumor activity of DNA reactive agents.

  1997cites this paper
• Different repair of O6-methylguanine occurring in DNA modified by MMS in vivo or in vitro.

  1997cites this paper
• Inhibition of DNA repair as a means of increasing the antitumor activity of DNA reactive agents.

  1997cites this paper
• O6-benzylguanine and its role in chemotherapy.

  1997cites this paper
• Point mutations in human O6-alkylguanine-DNA alkyltransferase prevent the sensitization by O6-benzylguanine to killing by N,N'-bis (2-chloroethyl)-N-nitrosourea.

  1996cites this paper
• Pharmacokinetics and metabolism in rats of 2,4-diamino-6-benzyloxy-5- nitrosopyrimidine, an inactivator of O6-alkylguanine-DNA alkyltransferase.

  1996cites this paper